GLUE
Monte Rosa Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Wednesday, January 4, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Monte Rosa Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Price reaction · baseline $7.78 (2023-01-03 close) · hit after-hours · 2 other GLUE headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+67%
120-day peak, hindsight
Typical move
13.3%
average across 9 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
MRT-2359
Phase 2 · Castration-Resistant Prostate Cancer (CRPC)
Full Press Release Details
Monte Rosa Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference.